Vicinitas Therapeutics develops DUBTAC-based targeted protein stabilizers to restore disease-relevant proteins and pursue new treatments for cancer and genetic disorders.
Vicinitas Therapeutics develops DUBTAC-based targeted protein stabilizers to restore disease-relevant proteins and pursue new treatments for cancer and genetic disorders.